https://www.selleckchem.com/products/b-ap15.html
31 per 0.1 G/L; p=0.035). In pwMS on CD20 mAbs, B-cell depletion decreased seroconversion (OR 0.52; p=0.038), whereas time since last DMT did not. Safety of SARS-CoV-2 vaccines in pwMS was excellent. Humoral response to SARS-CoV2 vaccines in pwMS is generally excellent. While reduced by immunosuppressive DMTs, most importantly by B-cell-depleting CD20 mAbs and S1PMs, seroconversion is still expected in the majority of patients. SARS-CoV2 vaccination should be offered to every MS patient. Humoral response to SARS-CoV2 vaccines in pwMS is
Aimer
Commentaire
Partagez
